Yesterday, ERBA Diagnostics announced that it has launched its fifth wholly owned subsidiary, ERBA Diagnostics Mexico S.A. The company and its subsidiaries develop, manufacture, and distribute proprietary diagnostic reagents, test kits, and instrumentation for autoimmune and infectious diseases.
Mexico’s IVD market is estimated by to be worth approximately $400 million. Immunochemistry, hematology/coagulation, and chemistry/urine analysis products comprise the majority of the market’s profits. ERBA Diagnostics focuses on these market segments, which is expected to create additional business opportunities in the near future. The company notes that the Mexican market for diagnostics is expected to grow approximately 15% per year.
ERBA Mexico is currently in the process of hiring sales specialists and customer support engineers for its Mexico City location. The sales and service training center will provide better support to ERBA Diagnostics’ distributors and customers throughout Latin America, with the ultimate goal of increasing sales and improving brand image.
For more information, please visit www.erbadiagnostics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
